Dergiler / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 6

Management of acute postoperative hypertension for reducing cardiovascular complications in cancer patients: when and how aggressively?

Sayfa
1634–1640
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: To reduce CVCs, APH may be defined and managed as a hypertensive crisis in cancer patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: We sought to determine what factors cardiovascular complications (CVCs) correlate with in cancer patients with acute postoperative hypertension (APH) and to define when and how aggressively to treat this disorder in the present study.
📊
Temel Bulgular & Veri:Materials and methods: A retrospective observational study of cancer patients with postoperative hypertension at a single intensive care unit between July 2007 and June 2013 was conducted.
💡
Sonuç & Katkı:Conclusion: To reduce CVCs, APH may be defined and managed as a hypertensive crisis in cancer patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: We sought to determine what factors cardiovascular complications (CVCs) correlate with in cancer patients with acute postoperative hypertension (APH) and to define when and how aggressively to treat this disorder in the present study. Materials and methods: A retrospective observational study of cancer patients with postoperative hypertension at a single intensive care unit between July 2007 and June 2013 was conducted. The outcome of interest was the incidence of a CVC. Results: There were 1162 patients enrolled, of which 92 (7.9%) experienced one or more CVCs. Preexisting hypertension (OR 38.3, 95% CI 3.2 457.4, P = 0.004) and choice of vasodilator (OR 6.5, 95% CI 2.3 18.6, P = 0.000) were predictors of a CVC. Cardiovascular complications were less likely to occur if pain was relieved efficiently during the postoperative period (OR 15.9, 95% CI 1.9 130.1, P = 0.01). Furthermore, there were increased CVCs among patients with postoperative hypertensive crises compared to those with stage 1 or stage 2 hypertension with the treatment threshold for systolic blood pressure (OR 5.7, 95% CI 2.0 16.5, P = 0.001) or diastolic blood pressure (OR 6.0, 95% CI 1.8 20.3, P = 0.004). Conclusion: To reduce CVCs, APH may be defined and managed as a hypertensive crisis in cancer patients.

🔖

Bu Makaleye Atıf Yap

LOU, N., WANG, D., WANG, Z., YE, W., LIU, X. (2022). Management of acute postoperative hypertension for reducing cardiovascular complications in cancer patients: when and how aggressively?. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 6, 1634–1640. https://ajindex.com/articles/610764

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 1953; 152: 1501-1504
  2. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, Gibbs J, Grover F, Hammermeister K, Stremple JF. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995; 180: 519-531
  3. Gal TJ, Cooperman LH. Hypertension in the immediate postoperative period. Br J Anaesth 1975; 47: 70-74
  4. Marik PE, Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anest 2009; 21: 220-229
  5. Haas CE, LeBlanc JM. Acute postoperative hypertension: a review of therapeutic options. Am J Health Syst Pharm 2004; 61: 1661-1673
  6. Weant KA, Flynn JD, Smith KM. Postoperative hypertension. Orthopedics 2004; 27: 1159-1161
  7. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007; 131: 1949-1962
  8. Sladen RN, Klamerus KJ, Swafford MW, Prough DS, Mann HJ, Leslie JB, Goldberg JS, Levitsky S, Molina JE, Mills SA. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting. J Cardiothorac Anest 1990; 4: 210-221
  9. Wang YN, Long H, Lin P, Lin YB, Lin ZC, Si-Tu DR, Ma G, Huang ZF, Rong TH. Influence of perioperative hypertension on postoperative cardiovascular complications in chest cancer patients. Ai Zheng 2007; 26: 537-540
  10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
  11. Desai RG, Muntazar M, Goldberg ME. Strategies for managing perioperative hypertension. Curr Hypertens Rep 2009; 11: 173-177
  12. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care 2003; 7: 374-384
  13. Rose DK, Cohen MM, DeBoer DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology 1996; 84: 772-781
  14. Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 2006; 21: S8-S14
  15. Leslie JB, Kalayjian RW, Sirgo MA, Plachetka JR, Watkins WD. Intravenous labetalol for treatment of postoperative hypertension. Anesthesiology 1987; 67: 413-416. 16. von Elm E, Altman D, Egger M, Poc